Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lactobacillus paracasei has been investigated for its potential to support urinary tract health, particularly in the prevention and management of urinary tract infections (UTIs). The rationale behind its use is based on the general concept that certain probiotic strains can help restore and maintain a healthy balance of the urogenital microbiota, which is often disrupted in individuals susceptible to UTIs. L. paracasei is known to produce lactic acid, lowering pH and inhibiting the growth of pathogenic bacteria such as Escherichia coli, the primary causative agent of UTIs.

There are a small number of clinical studies and in vitro experiments indicating that L. paracasei may adhere to uroepithelial cells, compete with pathogens, and modulate the immune response. For example, some randomized controlled trials with mixed probiotic formulations (including L. paracasei) have reported a reduction in UTI recurrence in women, but these studies often include other lactobacilli species, making it difficult to isolate the specific effects of L. paracasei. In vitro studies suggest possible mechanisms such as pathogen exclusion and immune modulation, but direct clinical evidence remains limited.

In summary, while there is a scientific rationale and preliminary evidence supporting the use of L. paracasei for UTI prevention, the overall evidence is still weak and largely extrapolated from broader studies on lactobacilli or multi-strain probiotics. More rigorous, strain-specific trials are needed to substantiate its effectiveness.

More about lactobacillus paracasei
More about Urinary Tract Infections

Other ingredients used for Urinary Tract Infections

Other health conditions supported by lactobacillus paracasei

Products containing lactobacillus paracasei